The independent source for health policy research, polling, and news.
13,201 - 13,220 of 112,408 Results
In remarks during a Chicago trip Thursday, President Joe Biden pressed more private-sector businesses to institute covid shot requirements: "They’re lifesaving, they’re game-changing for our country." Earlier in the day, the White House released a report on the role mandates have played on driving up vaccination rates.
Today's early morning highlights from the major news organizations.
Pfizer's application will be welcome news to many anxious parents, as the number of pediatric cases climb in the U.S. The Food and Drug Administration says it will quickly act on the application, with a meeting tentatively scheduled for Oct. 26. If that timing holds, the shot will not be available to kids until November.
Editorial writers tackle these public health issues.
Opinion writers tackle covid burnout, how to defeat the coronavirus and vaccinating while pregnant.
Meanwhile, as Cuba sells its covid vaccine, worries emerge over who'll buy it without World Health Organization approval. Separately, AP reports that the WHO is working to get covid medical supplies into North Korea, possibly indicating the secretive nation is seeking outside help.
Meanwhile, residents in Newark, New Jersey, remain unconvinced lead levels are safe five years after high levels were found in 30 schools' water systems. Opioid settlement money in Louisiana, postpartum Medicaid benefits, black lung, school violence and more are also in the news.
News outlets report on Facebook's response to scrutiny from lawmakers after testimony from a whistleblower. Separately, Snapchat publicly addressed purchases by young users of fentanyl-laced fake pills, and launched a new tool to connect users to substance abuse experts.
A study found the 15 most common types of cancer cost the U.S. around $156.2 billion annually. Separately, pandemic delays to cancer surgery were a global problem, with 15% of people putting off surgery in lockdowns. Breast cancer, a cancer "super-enhancer" and more are also in the news.
In other news, antibiotic-resistant infections were found to disproportionately affect older Americans; a patent lawsuit delays a Botox competitor; and the former CEO of grocery chain Safeway testified in the ongoing trial of Theranos founder Elizabeth Holmes.
Modern Healthcare reports that although fewer hospital mergers and acquisitions happened in 2021 than before, a high percentage of giant-sized transactions took place. The American Hospital Association is also reported to be urging Congress to stop upcoming cuts to Medicare.
People who have no proof or have an exemption can still enter a business briefly to use the restroom or pick up a takeout order, according to the ordinance. The law is set to go into effect Nov. 4.
AP reports that more than 120,000 children lost a primary caregiver during the pandemic, potentially a higher figure than estimated. Black and Hispanic American kids were disproportionately affected. Separate reports say covid is now the leading cause of death among police officers.
Meanwhile, sources have told Politico that the Biden administration is closing in on a nominee to lead the Food and Drug Administration.
The list of countries only administering one dose of the covid vaccine to adolescents is growing. The move is in response to the rare cases where a youngster develops myocarditis after a second shot. Meanwhile, Sweden and Denmark have halted use of Moderna's jab for those under 30. Other vaccine rollout developments are in the news.
The White House says its big purchase will quadruple access to rapid at-home tests by the end of the year. American demand for such kits has outpaced supply.
In a sharply worded opinion, U.S. District Judge Robert Pitman barred enforcement of the restrictive law, saying "From the moment S.B. 8 went into effect, women have been unlawfully prevented from exercising control over their lives in ways that are protected by the Constitution." The state of Texas quickly appealed for an emergency stay of Pitman's ruling.
GlaxoSmithKline's RTS,S vaccine, known as Mosquirix, is also the first vaccine recommended for use by the World Health Organization to combat a parasitic disease. There are hurdles ahead though: the four-dose regimen raises logistical challenges, while questions remain over who will pay for it.
Today's early morning highlights from the major news organizations.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
© 2026 KFF